| Name: | Cilostazol Related Compound A |
| Catalogue No. | VE006096 |
| CAS No. | 54197-66-9 |
| Molecular Formula | C9H9NO2 |
| Molecular Weight | 163.17 |
| Status | In-stock |
| IUPAC Name | 3,4-Dihydro-6-hydroxy-2(1H)-quinolinone |
| Appearance | Off White powder |
| Description | Cilostazol Related Compound A (CAS No: 54197-66-9) or 3,4-Dihydro-6-hydroxy-2(1H)-quinolinone is a metabolite of Cilostazol. Cilostazol is an antiplatelet agent and also depicts vasodilating properties. It has been evaluated in the treatment of patients with peripheral ischemia such as intermittent claudication. The drug blocks platelet aggregation caused by ADP, collagen, and arachidonic acid. Cilostazol inhibits both primary and secondary aggregation. It also depicts vascular vasodilator prope |
| References | Akiyama H, Kudo S, Shimizu T. The metabolism of a new antithrombotic and vasodilating agent, cilostazol, in rat, dog and man. Arzneimittel-forschung. 1985 ;35(7A):1133-1140. PMID: 4074424. https://europepmc.org/article/med/4074424 Sorkin EM, Markham A. Cilostazol. Drugs & Aging. 1999 Jan;14(1):63-71; discussion 72-3. DOI: 10.2165/00002512-199914010-00005. PMID: 10069409. https://europepmc.org/article/med/10069409 |
